3750 — Cytori Cell Research Institute Cashflow Statement
0.000.00%
Last trade - 00:00- ¥8bn
- ¥15bn
- ¥2bn
Annual cashflow statement for Cytori Cell Research Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 594 | 319 | -654 | -65.3 | -1,166 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -360 | — | 212 | -300 | 205 |
| Unusual Items | |||||
| Changes in Working Capital | -3,035 | 38.7 | 52 | -144 | 589 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,751 | 532 | -82.9 | -188 | -39.7 |
| Capital Expenditures | — | — | -16 | -180 | -159 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,376 | -7,424 | 22.7 | -36.1 | -125 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,376 | -7,424 | 6.7 | -216 | -283 |
| Financing Cash Flow Items | -55 | 1,033 | 377 | 76.4 | 55.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,937 | 6,358 | 151 | 35.8 | 294 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 562 | -534 | 70.2 | -368 | -28.5 |